Gilead Sciences Inc. (0QYQ)
LSE
Real-time Data
07:00 AM
Day's Range
142.0552 wk Range
108.50Overview - 0QYQ - Gilead Sciences Inc.
Key Statistics
Valuation
Enterprise Value
115.75B
P/E (Trailing)
‪33.67‬
PEG Ratio
‪-0.05‬
Price / Sales (TTM)
‪6.66‬
Price / Book
‪8.63‬
EV / EBITDA
‪9.51‬
Profitability
Gross Margin
‪79.76%‬
Profit Margin
‪20.02%‬
Operating Margin
‪35.75%‬
Return on Assets
‪9.77%‬
Return on Equity
‪26.34%‬
Ownership
Shares Outstanding
1.24B
Float
1.24B
Held by Insiders
‪0.10%‬
Held by Institutions
‪86.84%‬
Price stats
Beta
‪0.34‬
50-Day Avg
‪131.81‬
200-Day Avg
‪133.37‬
Dividends
Payout Ratio
‪68.05%‬
Frequency
Quarterly
Market Cap - 0QYQ - Gilead Sciences Inc.
Peers - 0QYQ - Gilead Sciences Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on LSE.
- 0QYQLSEGilead Sciences Inc.182.54BMarket Cap+21.84%52-week change33.45P/E (Trailing)‪20.02%‬Profit Margin
- AZNLSEAstraZeneca PLC22.41TMarket Cap+29.32%52-week change28.74P/E (Trailing)‪17.18%‬Profit Margin
- GSKLSEGSK plc7.68TMarket Cap+23.02%52-week change16.26P/E (Trailing)‪14.52%‬Profit Margin
- 0QIULSENovo Nordisk A/S1.24TMarket Cap-23.24%52-week change19.95P/E (Trailing)‪33.39%‬Profit Margin
- 0Q1GLSEEli Lilly and Company686.33BMarket Cap+54.90%52-week change1.56P/E (Trailing)‪33.52%‬Profit Margin
- 0QCVLSEAbbVie Inc.478.52BMarket Cap+21.83%52-week change54.73P/E (Trailing)‪15.50%‬Profit Margin
- 0QAHLSEMerck & Co., Inc.383.85BMarket Cap+44.02%52-week change63.23P/E (Trailing)‪5.33%‬Profit Margin
Profile Summary - 0QYQ - Gilead Sciences Inc.
About
Gilead Sciences Inc. is a biopharmaceutical company that discovers, develops, and commercializes medicines addressing unmet medical needs in infectious diseases, oncology, and other therapeutic areas across the United States, Europe, and international markets. Its portfolio centers on HIV treatments, including leading…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
